Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Cell Stem Cell

Tracked across 7 events · 45 articles · First seen Jul 02, 2026 · Last active Sep 21, 2026

Sentiment
10
Attention
4
Events
7
Relationships
4
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
1 10
Business
Regenerative Medical Technology Group, Inc. (RMTG), through its Cellgenic division, announced on September 8, 2026, that it has commenced local commercial arrangements in Colombia, including establishing local representation and developing relationships with physicians and medical…
Impact: Wholly owned subsidiary through which RMTG operates; benefits from expansion.
Sep 08, 2026 · 6 articles
1 8
Business
Regenerative Medical Technology Group, Inc. (OTCID:RMTG) announced on September 17, 2026 the launch, through its ISSCA division, of a new Integrative Fellowship in Point-of-Care Regenerative Medicine. The fellowship is described as ISSCA's most comprehensive credential…
Impact: As the wholly owned subsidiary through which RMTG operates and the parent of ISSCA, it is the operating vehicle for the new fellowship and the broader physician-education network spanning more than 30 countries.
Sep 17, 2026 · 6 articles
1 8
Business
Regenerative Medical Technology Group announced that its physician-education platform, the International Society for Stem Cell Application, will host the ISSCA 125 Global Summit from September 25-27, 2026 at the JW Marriott Cancun Resort and Spa…
Impact: As the wholly owned subsidiary operating the ISSCA physician-education platform, it is the vehicle through which the summit is conducted and its ecosystem is showcased.
Sep 21, 2026 · 6 articles
0 10
Business
Impact: Wholly owned subsidiary of RMTG, through which the expansion is conducted.
Jul 23, 2026 · 6 articles
0 20
Business
Impact: As RMTG's wholly owned subsidiary, Cell Stem Cell is the operational driver behind the growth discussed, benefiting from increased visibility.
Aug 05, 2026 · 9 articles
4 10
Tech
Impact: Cell Stem Cell is the journal that published the research, providing a platform for the scientific community to access these findings.
Jul 02, 2026 · 6 articles
0 5
Business
Impact: Cell Stem Cell is the wholly owned subsidiary through which RMTG operates. The website launch indirectly supports its parent's investor relations but has no direct operational impact.
Aug 26, 2026 · 6 articles
David Christensen ↔ Cell Stem Cell
Regenerative Medical Technology Group subsidiary ↔ Cell Stem Cell Cell Stem Cell is a wholly owned operating subsidiary of Regenerative Medical Te
David Christensen executive ↔ Cell Stem Cell David Christensen is the CEO and President of Regenerative Medical Technology Gr
Regenerative Medical Technology Group parent ↔ Cell Stem Cell Regenerative Medical Technology Group wholly owns Cell Stem Cell, which function
ERGEN INTELLIGENCE
Track Cell Stem Cell live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.